# FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/par-23-072-fda-support-for-conferences-and-scientific-meetings-r13/  
Official notice: https://www.grants.gov/search-results-detail/344880

> Food and Drug Administration offered grants to nonprofits, state and local governments, tribes and businesses. It expected to make about 20 awards worth $1.0 million in total. Applications closed on January 30, 2026.

| Field | Value |
|---|---|
| Opportunity number | PAR-23-072 |
| Agency | Food and Drug Administration |
| Status | Forecast |
| Deadline | January 30, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 20 |
| Total funding | $1.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- County governments
- City or township governments
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Foreign Institutions are not eligible to apply

## What the grant funds

The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission. Permission to submit a conference grant application does not assure funding or funding at the level requested. FDA will not issue a conference grant award unless it can be issued before the conference start date.

## Questions people ask

### Is PAR-23-072 still open?

No. It closed on January 30, 2026. A newer notice is open: PAR-27-017, rolling or no fixed deadline.

### Who can apply for FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)?

Food and Drug Administration accepted applications from nonprofits, state and local governments, tribes and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)?

Closed January 30, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $1.0 million in total across about 20 awards.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.